Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Heist

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The Oncologist|November 27, 2013
Adjuvant therapy for a 3.9-cm adenocarcinoma of the lungRebecca Heist, Christopher G Azzoli
The Annals of Thoracic Surgery|August 13, 2013
The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancersBenjamin Izar, Lecia Sequist, Mihan Lee, et al.
Journal of General Internal Medicine|November 7, 2009
Code status documentation in the outpatient electronic medical records of patients with metastatic cancerJennifer S Temel, Joseph A Greer, Sonal Admane, et al.
The Oncologist|August 3, 2011
Tumor epidermal growth factor receptor genotype and depression in stage IV non-small cell lung cancerWilliam F Pirl, Lara Traeger, Joseph A Greer, et al.
Future Oncology (London, England)|January 6, 2026
MDX-2001-101 study protocol: a phase I/IIa, multicenter, first-in-human, open-label clinical trial evaluating MDX2001 monotherapy in patients with advanced solid tumorsEcaterina Dumbrava, Anna Minchom, Jason Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2018
Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: Results From the CA209-003 StudyScott Gettinger, Leora Horn, David Jackman, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2011
Cigarette smoking increases copy number alterations in nonsmall-cell lung cancerYen-Tsung Huang, Xihong Lin, Yan Liu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 5, 2025
US expert Delphi consensus on the prevention and management of stomatitis in patients treated with datopotamab deruxtecanHope Rugo, Aditya Bardia, Debora S Bruno, et al.
Investigational New Drugs|June 29, 2022
First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumorsTodd Bauer, Byong Chul Cho, Rebecca Heist, et al.
Future Oncology (London, England)|November 8, 2024
Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib studyLyudmila Bazhenova, Dong-Wan Kim, Byoung Chul Cho, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Oncologist|November 27, 2013
Adjuvant therapy for a 3.9-cm adenocarcinoma of the lungRebecca Heist, Christopher G Azzoli
The Annals of Thoracic Surgery|August 13, 2013
The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancersBenjamin Izar, Lecia Sequist, Mihan Lee, et al.
Journal of General Internal Medicine|November 7, 2009
Code status documentation in the outpatient electronic medical records of patients with metastatic cancerJennifer S Temel, Joseph A Greer, Sonal Admane, et al.
The Oncologist|August 3, 2011
Tumor epidermal growth factor receptor genotype and depression in stage IV non-small cell lung cancerWilliam F Pirl, Lara Traeger, Joseph A Greer, et al.
Future Oncology (London, England)|January 6, 2026
MDX-2001-101 study protocol: a phase I/IIa, multicenter, first-in-human, open-label clinical trial evaluating MDX2001 monotherapy in patients with advanced solid tumorsEcaterina Dumbrava, Anna Minchom, Jason Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2018
Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: Results From the CA209-003 StudyScott Gettinger, Leora Horn, David Jackman, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2011
Cigarette smoking increases copy number alterations in nonsmall-cell lung cancerYen-Tsung Huang, Xihong Lin, Yan Liu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 5, 2025
US expert Delphi consensus on the prevention and management of stomatitis in patients treated with datopotamab deruxtecanHope Rugo, Aditya Bardia, Debora S Bruno, et al.
Investigational New Drugs|June 29, 2022
First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumorsTodd Bauer, Byong Chul Cho, Rebecca Heist, et al.
Future Oncology (London, England)|November 8, 2024
Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib studyLyudmila Bazhenova, Dong-Wan Kim, Byoung Chul Cho, et al.
Pageof 2